Discounted Cash Flow Rating
Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Wall Street Data Solutions Rating
Neutral
B
Allakos Inc. (ALLK)
Pharmaceutical Preparations
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells.
825 INDUSTRIAL ROAD, SUITE 500
SAN CARLOS, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
07/19/2018
Market Cap
56,846,678
Shares Outstanding
87,480,000
Weighted SO
87,476,338
Total Employees
N/A
Upcoming Earnings
08/14/2024
Beta
0.8650
Last Div
0.0000
Range
0.6348-3.41
Chg
-0.0177
Avg Vol
593264
Mkt Cap
56846678
Exch
NASDAQ
Country
US
Phone
650 597 5002
DCF Diff
0.3509
DCF
0.2877
Div Yield
0.0000
P/S
5.2851
EV Multiple
-0.3840
P/FV
0.6752
Div Yield %
0.0000
P/E
-0.2753
PEG
-0.0048
Payout
0.0000
Current Ratio
3.5654
Quick Ratio
3.5654
Cash Ratio
0.7385
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
1167.1166
CCC
-1167.1166
Gross Margin
0.5313
Op Margin
-17.4366
Pretax Margin
-19.1520
Net Margin
-19.1520
Eff Tax Rate
-0.0252
ROA
-1.3166
ROE
-1.4260
ROCE
-1.5554
NI/EBT
1.0000
EBT/EBIT
1.0984
EBIT/Rev
-17.4366
Debt Ratio
0.2540
D/E
0.4730
LT Debt/Cap
0.3034
Total Debt/Cap
0.3211
Int Coverage
-70.9871
CF/Debt
-2.5975
Equity Multi
1.8626
Rec Turnover
0.0000
Pay Turnover
0.3127
Inv Turnover
0.0000
FA Turnover
0.4011
Asset Turnover
0.0687
OCF/Share
-1.1643
FCF/Share
-1.1657
Cash/Share
1.3889
OCF/Sales
-9.5955
FCF/OCF
1.0012
CF Coverage
-2.5975
ST Coverage
-32.7128
CapEx Coverage
-867.3025
Div&CapEx Cov
-867.3025
P/BV
0.6752
P/B
0.6752
P/S
5.2851
P/E
-0.2753
P/FCF
-0.5502
P/OCF
-0.5495
P/CF
-0.5495
PEG
-0.0048
P/S
5.2851
EV Multiple
-0.3840
P/FV
0.6752
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | X | X | X | X | X | ▲ 10.76M | ▼ 0.00 |
Cost Of Revenue | X | X | X | X | ▲ XXXXXXX | ▼ 1.55M | ▼ 1.07M |
Gross Profit | X | X | X | X | ▼ -XXXXXXX | ▲ 9.21M | ▼ -1.07M |
Gross Profit Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | ▲ 0.86 | ▼ 0.00 |
Research And Development Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 52.25M | ▼ 33.75M |
General And Administrative Expenses | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 11.18M | ▼ 10.90M |
Selling And Marketing Expenses | X | X | X | X | X | 0.00 | 0.00 |
Selling General And Administrative Expenses | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 11.18M | ▼ 10.90M |
Other Expenses | -XXXXX | ▼ -XXXXX | ▼ -XXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ 50.00K | ▼ -72.00K |
Operating Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 63.44M | ▼ 44.65M |
Cost And Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 64.98M | ▼ 45.72M |
Interest Income | X | X | ▲ XXXXXX | ▼ XXXXX | ▲ XXXXXXX | ▼ 2.38M | ▼ 2.00M |
Interest Expense | XXXXXXX | ▲ XXXXXXX | ▼ X | X | ▲ XXXXXXX | ▼ 2.64M | ▼ 0.00 |
Depreciation And Amortization | XXXXX | ▲ XXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 1.55M | ▼ 1.07M |
Ebitda | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -63.44M | ▲ -44.65M |
Ebitda Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | ▼ -5.90 | ▲ 0.00 |
Operating Income | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -64.98M | ▲ -45.72M |
Operating Income Ratio | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | ▼ -6.04 | ▲ 0.00 |
Total Other Income Expenses Net | -XXXXX | ▼ -XXXXX | ▼ -XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ 2.43M | ▼ -25.42M |
Income Before Tax | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -62.55M | ▼ -71.15M |
Income Before Tax Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | ▼ -5.82 | ▲ 0.00 |
Income Tax Expense | -XXXXXXX | ▲ XXXXX | ▲ XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▲ 6.75M | ▼ 0.00 |
Net Income | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -62.55M | ▼ -71.15M |
Net Income Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | ▼ -5.82 | ▲ 0.00 |
Eps | -X.XX | ▼ -X.XX | ▼ -X.XX | ▼ -X.XX | ▲ -X.XX | ▼ -0.71 | ▼ -0.81 |
Eps Diluted | -X.XX | ▼ -X.XX | ▼ -X.XX | ▼ -X.XX | ▲ -X.XX | ▼ -0.71 | ▼ -0.81 |
Weighted Average Shs Out | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 87.57M | ▲ 88.04M |
Weighted Average Shs Out Dil | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 87.57M | ▲ 88.04M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXX | ▼ 66.44M | ▼ 43.06M |
Short Term Investments | XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 104.35M | ▼ 96.19M |
Cash And Short Term Investments | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 170.79M | ▼ 139.25M |
Net Receivables | X | X | X | X | X | 0.00 | 0.00 |
Inventory | X | X | X | X | X | 0.00 | 0.00 |
Other Current Assets | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 9.10M | ▼ 8.38M |
Total Current Assets | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 179.89M | ▼ 147.63M |
Property Plant Equipment Net | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 57.51M | ▼ 27.94M |
Goodwill | X | X | X | X | X | 0.00 | 0.00 |
Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Goodwill And Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Long Term Investments | X | X | X | X | ▲ XXXXXXX | 1.47M | 1.47M |
Tax Assets | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Assets | XXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 4.74M | ▼ 265.00K |
Total Non Current Assets | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 63.72M | ▼ 29.68M |
Other Assets | X | X | X | X | X | 0.00 | 0.00 |
Total Assets | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 243.61M | ▼ 177.31M |
Account Payables | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXX | ▼ 1.76M | ▲ 15.75M |
Short Term Debt | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 3.25M | ▼ 3.02M |
Tax Payables | X | X | X | X | X | 0.00 | 0.00 |
Deferred Revenue | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ X | ▼ -1.76M | ▲ 0.00 |
Other Current Liabilities | XXXXX | ▲ XXXXX | ▼ XXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ 33.33M | ▼ 17.15M |
Total Current Liabilities | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 36.58M | ▼ 35.92M |
Long Term Debt | X | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 38.22M | ▼ 37.41M |
Deferred Revenue Non Current | X | X | X | X | X | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Liabilities | XXXXXXX | ▼ X | X | X | X | 0.00 | ▼ -1.00 |
Total Non Current Liabilities | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 38.22M | ▼ 37.41M |
Other Liabilities | X | X | X | X | X | 0.00 | ▲ 1.00 |
Capital Lease Obligations | XXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 38.22M | ▼ 37.41M |
Total Liabilities | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 74.79M | ▼ 73.33M |
Preferred Stock | X | X | X | X | X | 0.00 | 0.00 |
Common Stock | XXXXX | ▲ XXXXX | ▲ XXXXX | ▲ XXXXX | ▲ XXXXX | ▲ 88.00K | ▲ 89.00K |
Retained Earnings | -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -1.12B | ▼ -1.19B |
Accumulated Other Comprehensive Income Loss | -XXXXX | ▲ XXXXXX | ▼ XXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▲ 50.00K | ▼ 20.00K |
Other Total Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXXX | ▲ XXXXXXXXXX | ▲ 1.29B | ▲ 1.29B |
Total Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 168.82M | ▼ 103.98M |
Total Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 168.82M | ▼ 103.98M |
Total Liabilities And Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 243.61M | ▼ 177.31M |
Minority Interest | X | X | X | X | X | 0.00 | 0.00 |
Total Liabilities And Total Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 243.61M | ▼ 177.31M |
Total Investments | XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 105.83M | ▼ 97.66M |
Total Debt | XXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 41.47M | ▼ 40.43M |
Net Debt | -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXXX | ▲ -XXXXXXXXX | ▲ -XXXXXXXX | ▲ -24.98M | ▲ -2.63M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -62.55M | ▼ -71.15M |
Depreciation And Amortization | XXXXX | ▲ XXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 1.55M | ▼ 1.07M |
Deferred Income Tax | X | ▼ -XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▼ X | ▼ -13.30M | ▲ 0.00 |
Stock Based Compensation | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▲ 10.20M | ▼ 6.21M |
Change In Working Capital | -XXXXX | ▼ -XXXXXX | ▼ -XXXXXXX | ▲ XXXXXXXX | ▼ -XXXXXXXX | ▲ 27.07M | ▼ 3.79M |
Accounts Receivables | X | X | X | X | X | 0.00 | 0.00 |
Inventory | X | X | X | X | X | 0.00 | 0.00 |
Accounts Payables | -XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXX | ▲ 864.00K | ▲ 13.98M |
Other Working Capital | XXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▲ XXXXXXX | ▼ -XXXXXXXX | ▲ 26.21M | ▼ -10.20M |
Other Non Cash Items | -XXXXXX | ▲ XXXXX | ▲ XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXXX | ▲ 12.76M | ▲ 21.90M |
Net Cash Provided By Operating Activities | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -24.27M | ▼ -32.54M |
Investments In Property Plant And Equipment | -XXXXXXX | ▲ -XXXXX | ▼ -XXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXX | ▲ 34.00K | ▼ -4.00K |
Acquisitions Net | -XXXXXXXX | ▲ X | X | X | ▲ XXXXX | ▼ -20.16K | ▲ 0.00 |
Purchases Of Investments | -XXXXXXXX | ▼ -XXXXXXXXX | ▲ -XXXXXXXXX | ▲ -XXXXXXXXX | ▲ -XXXXXXXX | ▲ -29.85M | ▼ -34.37M |
Sales Maturities Of Investments | XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ 50.00M | ▼ 43.40M |
Other Investing Activities | XXXXXXXX | ▼ X | X | X | ▼ -XXXXX | ▲ 20.16K | ▲ 9.03M |
Net Cash Used For Investing Activities | -XXXXXXX | ▼ -XXXXXXXXX | ▲ -XXXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▲ 20.19M | ▼ 9.03M |
Debt Repayment | X | X | X | X | ▼ -XXXXXX | ▼ -3.12M | ▲ 0.00 |
Common Stock Issued | X | X | ▲ XXXXXXXXX | ▼ XXXXXX | ▲ XXXXXXXXX | ▼ -1.07M | ▲ 132.00K |
Common Stock Repurchased | X | X | X | X | X | 0.00 | 0.00 |
Dividends Paid | X | X | X | X | X | 0.00 | 0.00 |
Other Financing Activities | XXXX | ▲ XXXX | ▲ XXXXXXX | ▼ XXXXX | ▼ -XXXXXXXXX | ▲ 4.89M | ▼ 26.00K |
Net Cash Used Provided By Financing Activities | XXXX | ▲ XXXX | ▲ XXXXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ 696.00K | ▼ 132.00K |
Effect Of Forex Changes On Cash | X | X | X | X | X | ▲ 48.07M | ▼ 0.00 |
Net Change In Cash | -XXXXXXXX | ▼ -XXXXXXXXX | ▲ XXXXXXXXX | ▼ -XXXXXXXXX | ▲ -XXXXXXXXX | ▲ -4.08M | ▼ -23.38M |
Cash At End Of Period | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXX | ▼ 66.44M | ▼ 43.06M |
Cash At Beginning Of Period | XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 70.52M | ▼ 66.44M |
Operating Cash Flow | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -24.27M | ▼ -32.54M |
Capital Expenditure | -XXXXXXX | ▲ -XXXXX | ▼ -XXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXX | ▲ 34.00K | ▼ -4.00K |
Free Cash Flow | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -24.23M | ▼ -32.54M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Upgrade To Get Access
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Dicta eveniet ex illo maxime minima numquam quibusdam reprehenderit temporibus vel, voluptatum? Delectus eos eveniet id iusto necessitatibus, neque porro unde voluptatibus. Aut blanditiis commodi, iste iure laborum pariatur temporibus. Atque distinctio dolore, doloremque eaque eius harum inventore laudantium quibusdam recusandae voluptatibus.